Seaport Therapeutics, Inc. Common Stock Financial Flexibility Index
Seaport Therapeutics, Inc. Common Stock financial flexibility index. Seaport Therapeutics, Inc. Common Stock (SPTX) has a Financial Flexibility Index of -1.37x as of June 2026. Free cash flow of $-26.14 Million (operating CF $-26.14 Million minus capex $0.00) represents -1% of total liabilities ($19.08 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Seaport Therapeutics, Inc. Common Stock (2024–2025)
Financial flexibility index of Seaport Therapeutics, Inc. Common Stock from 2024 to 2025. Historical Financial Flexibility Index trend for Seaport Therapeutics, Inc. Common Stock across 2 annual periods. Explore Seaport Therapeutics, Inc. Common Stock (SPTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Seaport Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2024–2025)
Seaport Therapeutics, Inc. Common Stock financial flexibility index by year from 2024 to 2025. Year-by-year free cash flow to debt coverage for Seaport Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see Seaport Therapeutics, Inc. Common Stock (SPTX) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-77.59 Million | $-77.94 Million | $341.55 Million | ▼ -162.1% |
| 2024 | -0.09x | $-29.52 Million | $-29.63 Million | $340.63 Million | — |